UPDATE: Bellicum Pharma Announces Successful First Dosing for Patient Cohort with BPX-501
January 13, 2015 at 07:03 AM EST
Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel ...